Convincing new Norwegian heart sensor

The innovative ECG247 heart sensor, developed and manufactured in Norway, proves to be better in a direct comparison than the cardiac arrhythmia detection devices previously used by most hospitals and cardiac specialists worldwide. This is the finding of a new study published in the Journal of Healthcare Engineering. "ECG247 makes it easier to detect severe cardiac arrhythmias before they cause symptoms," says Tord Ytterdahl, developer and CEO of Appsens AS and ECG247.
The ECG247 heart sensor was developed in collaboration with researchers at Sorlandet Hospital and the University of Agder. The system consists of a small, reusable sensor that is attached over the sternum with a special patch. The sensor communicates with an app on the smartphone and uses artificial intelligence to analyze the heart rhythm in real time. The results can be easily shared with a primary care physician or cardiologist. ECG247 is already used by many GPs and cardiologists in Norway.
Edvard L. Sandberg, a physician and doctoral student at Sorlandet Hospital, in collaboration with researchers at Oslo University Hospital and St. Olavs Hospital, compared the ECG247 heart sensor with standard hospital equipment for detecting cardiac arrhythmias (known as a Holter examination or long-term ECG). In the study, both systems were applied to 150 patients for several days. The ECG247 sensor detected arrhythmias as well as Holter technology, but had far fewer erroneous test results. In addition, the study showed that ECG247 was easier and more convenient to use than a conventional Holter device.
Atrial fibrillation is the most common cardiac arrhythmia and is associated with an increased risk of stroke, heart failure, dementia and premature death, among others. However, if the condition is caught early enough, there are good preventive medications. Ytterdahl hopes the study can contribute to wider international adoption of ECG247. In entering the German market, the european accelerator Startup Campus Germany is providing support. Startup Campus works in particular with startups in the fields of digital health and Industry 4.0. The aim is to provide professional preparation before entering the German market and comprehensive support during the process in order to build long-term partnerships. Through the cooperation with numerous startups, it became apparent that reaching out to a global market is challenging. Startup Campus Germany builds bridges between international ecosystems and supports the internationalization of startups. This includes dealing with local regulations, cultural differences and global precautions, among other things.
"After more than 4 years of development, we are proud that ECG247 is now medically certified and available to everyone in pharmacies. The study confirms that ECG247 is reliable, accurate and easy to use." Ytterdahl hopes early detection of cardiac arrhythmias with ECG247 will help prevent serious complications such as stroke. "Many people who experience palpitations from time to time can now easily test themselves," he says.
For more information about ECG247, visit www.ecg247.com. 
Link to the study mentioned: "Diagnostic Accuracy and Usability of the ECG247 Smart Heart Sensor Compared to Conventional Holter Technology." 
https://www.hindawi.com/journals/jhe/2021/5230947/

Startup Campus Germany UG

Rosenheimer Straße 143/C 81671 München

www.startupcampusgermany.com

Startup Campus Germany is an european accelerator and helps Startups entering the German market.

This release was published on openPR.